KOL kliniske forsøg i El Paso, TX
5 studier for KOL søger deltagere på steder i og omkring El Paso (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RekruttererFase 3
- Research Site, El Paso
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RekruttererFase 3
- El Paso Pulmonary Association- Site Number : 8400033, El Paso
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RekruttererFase 2
- Research Site, El Paso
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RekruttererFase 3
- Research Site, El Paso
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RekruttererFase 3
- GSK Investigational Site, El Paso
KOL forsøg i andre byer
- Philadelphia, PA23 studier
- Miami, FL18 studier
- Birmingham, AL17 studier
- Boston, MA17 studier
- Orlando, FL15 studier
- Houston, TX15 studier
- Baltimore, MD14 studier
- Chicago, IL14 studier
- Dallas, TX12 studier
- Pittsburgh, PA12 studier
- New York City, NY11 studier
- Ann Arbor, MI10 studier
Andre studier i El Paso
- Overvægt10 studier
- Overvægt8 studier
- Hjertesvigt7 studier
- Ikke-småcellet lungecancer6 studier
- Brystkræft6 studier
- Metastatisk cancer5 studier
- Burkitts lymfom4 studier
- Lungecancer4 studier
- Astma4 studier
- Kræft (alle typer)4 studier
- Idiopatisk pulmonal fibrose4 studier
- Lupus4 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.